The content is available as a PDF (36.4 KB).
. 2006 Apr 5;6:449–451. doi: 10.1100/tsw.2006.89
Common Neuroprotective Effects of Endothelin Receptor A Blockade and Erythropoietin During Hypoxia-Associated Cell Injury. Perspectives of Combined Treatment
Lusine Danielyan
1,*, Gayane H Buniatian
2, Christoph H Gleiter
1
Lusine Danielyan
1
Department of Clinical Pharmacology,
University Hospital of Tuebingen,
Otfried-Mueller Str. 45,
D-72076 Tuebingen,
Germany
Find articles by Lusine Danielyan
Gayane H Buniatian
2
Institute of Biochemistry,
Medical Faculty of University of Leipzig,
Liebig Str. 16,
D-04103,
Leipzig,
Germany
Find articles by Gayane H Buniatian
Christoph H Gleiter
1
Department of Clinical Pharmacology,
University Hospital of Tuebingen,
Otfried-Mueller Str. 45,
D-72076 Tuebingen,
Germany
Find articles by Christoph H Gleiter
1
Department of Clinical Pharmacology,
University Hospital of Tuebingen,
Otfried-Mueller Str. 45,
D-72076 Tuebingen,
Germany
2
Institute of Biochemistry,
Medical Faculty of University of Leipzig,
Liebig Str. 16,
D-04103,
Leipzig,
Germany
✉
*Lusine Danielyan: lusine.danielyan@med.uni-tuebingen.de
Academic Editor: Martin Goette
Received 2006 Feb 27; Revised 2006 Mar 27; Accepted 2006 Apr 5; Collection date 2006.
Keywords: ischemia, stroke, Alzheimer's disease, neurodegeneration, apoptosis, neurons, astrocytes, proliferation, differentiation, endothelin receptor A antagonist, endothelin receptor B antagonist, BQ-123, BQ-788, erythropoietin
Copyright © 2006 Lusine Danielyan et al.
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
PMCID: PMC5917169 PMID: 16604256